Viscap Film Tablet 30 Mg
In the realm of medical advancements, Viscap shines as a beacon of hope for individuals grappling with hyperparathyroidism, a condition intricately linked to chronic kidney disease, parathyroid cancer, and primary hyperparathyroidism. This comprehensive guide unveils the essential facets, elucidating its indications, dosage guidelines, contraindications, precautions, and availability.
| Dosage form | |
|---|---|
| Pack size | |
| Potency | 30 Mg |
| Manufacturer | |
| Origin | |
| Generic Name (Ingredient) | Each Tablet Contains 33, 06 Mg Of Cinacalcet Hydrochloride Equivalent To 30 Mg Of Cinacallet. |
Assuming your emergency circumstances for this product, visit Urgent Quotation page. Besides, for any pharmaceutical questions, please ask us in the comments section.
Description
Active Ingredient: Cinacalcet
Viscap harnesses the power of Cinacalcet, a calcimimetic agent that revolutionizes the management of hyperparathyroidism. This remarkable compound enhances the sensitivity of the calcium-sensing receptor (CaSR) on the parathyroid gland, redefining the body’s response to extracellular calcium levels. The ultimate result is a reduction in parathyroid hormone (PTH) secretion, which translates to a decrease in serum calcium levels.
Indications
Viscap emerges as a critical therapeutic tool for a spectrum of conditions:
- Secondary Hyperparathyroidism (HPT) in Adult CKD Patients on Dialysis: Viscap plays a pivotal role in addressing secondary HPT, a common complication in adult patients with chronic kidney disease who rely on dialysis for renal support.
- Hypercalcemia in Adult Patients with Parathyroid Carcinoma: For those battling parathyroid cancer, Viscap serves as a potent ally in regulating calcium levels.
- Severe Hypercalcemia in Adult Patients with Primary HPT Unsuitable for Parathyroidectomy: When primary hyperparathyroidism poses a formidable challenge, Viscap steps in as a valuable therapeutic option.
Dosage and Administration
To maximize the benefits of Viscap, a systematic approach to dosage and administration is paramount. The recommended starting oral dose stands at 30 mg, administered twice daily. Subsequently, dosage adjustments should be made every 2 to 4 weeks, with incremental increases to 60 mg twice daily, 90 mg twice daily, and, if necessary, 90 mg thrice or four times daily. This meticulous titration process ensures the normalization of serum calcium levels.
Contraindications and Precautions
While Viscap offers a path to relief, it’s crucial to consider contraindications and exercise due precautions:
- Contraindications: Viscap should not be embraced by individuals displaying hypersensitivity to the medication.
- Precautions: Special care is advised for patients with moderate-to-severe hepatic impairment and underlying cardiovascular conditions. Initiation of Viscap is not recommended for hypocalcemic patients. Regular monitoring of serum calcium and phosphorus levels is essential, both before treatment commencement and during maintenance. Caution should also be exercised regarding the potential for a significant reduction in serum calcium levels, which may affect the seizure threshold. Furthermore, attention should be directed towards the development of adynamic bone disease if intact parathyroid hormone (iPTH) levels fall below 100 pg/mL. It’s noteworthy that its safety and efficacy in patients under 18 years of age remain unestablished.
Availability
Viscap extends its therapeutic reach to Turkey, where it is readily available at pharmacies. A pack of 28 tablets. This medication is also accessible in the United Arab Emirates.
The Mechanism
Viscap’s core component, Cinacalcet, works by enhancing the sensitivity of the calcium-sensing receptor (CaSR) on the parathyroid gland. In individuals with chronic kidney disease, secondary hyperparathyroidism arises due to heightened PTH secretion, a result of compromised kidney function in regulating phosphate excretion and vitamin D activation. Cinacalcet’s ability to curtail PTH secretion leads to a reduction in serum calcium and phosphate levels, effectively rectifying mineral metabolism in these patients.
Conclusion
Viscap stands as a testament to medical innovation, offering a lifeline to individuals navigating the complex terrain of hyperparathyroidism. By acquainting oneself with its indications, dosage nuances, contraindications, precautions, and availability, individuals can confidently incorporate it into their treatment journey, reaping the rewards of enhanced health and well-being.
Use the form below to report an error
Please answer the questions as thoroughly and accurately as possible. Your answers will help us better understand what kind of mistakes happen, why and where they happen, and in the end the purpose is to build a better archive to guide researchers and professionals around the world.
The information on this page is not intended to be a substitute for professional medical advice, diagnosis, or treatment. always seek the advice for your physician or another qualified health provider with any questions you may have regarding a medical condition. Always remember to
- Ask your own doctor for medical advice.
- Names, brands, and dosage may differ between countries.
- When not feeling well, or experiencing side effects always contact your own doctor.
Cyberchondria
The truth is that when we’re sick, or worried about getting sick, the internet won’t help.
According to Wikipedia, cyberchondria is a mental disorder consisting in the desire to independently make a diagnosis based on the symptoms of diseases described on Internet sites.
Why you can't look for symptoms on the Internet
If diagnoses could be made simply from a textbook or an article on a website, we would all be doctors and treat ourselves. Nothing can replace the experience and knowledge of specially trained people. As in any field, in medicine there are unscrupulous specialists, differences of opinion, inaccurate diagnoses and incorrect test results.
Reviews
There are no reviews yet.